The clinical implication and molecular mechanism of preferential IL-4 production by modified glycolipid-stimulated NKT cells
J. Clin. Invest. Shinji Oki, et al. 113:1631
doi:10.1172/JCI20862 [Go to this article.]

Problems with a PDF?